[112] Abdelhadi, O. et al. (2024), “Private Equity–Acquired Physician Practices And Market Penetration Increased Substantially, 2012–21”, Health Affairs, Vol. 43/3, pp. 354-362, https://doi.org/10.1377/hlthaff.2023.00152.
[69] Anderson, D. et al. (2020), “Occupational Licensing and Maternal Health: Evidence from Early Midwifery Laws”, Journal of Political Economy, Vol. 128/11, pp. 4337-4383, https://doi.org/10.1086/710555.
[88] Authority for Consumers and Markets (2025), ACM recommends Dutch health ministry: mandate opening up health-care information systems to promote innovation, https://www.acm.nl/en/publications/acm-recommends-dutch-health-ministry-mandate-opening-health-care-information-systems-promote-innovation.
[31] Authority for Consumers and Markets (2024), Choosing a health-insurance plan is still difficult for consumers, https://www.acm.nl/en/publications/choosing-health-insurance-plan-still-difficult-consumers.
[46] Autoridade da Concorrência (2021), Competition in Hemodialysis Care Provision in Portugal, https://extranet.concorrencia.pt/PesquisAdC/EPR.aspx?IsEnglish=True&Ref=EPR_2019_7.
[79] Autorité de la Concurrence (2019), Avis 19-A-18 du 31 décembre 2019 relatif à plusieurs projets de décret portant modification des codes de déontologie de certaines professions de santé, https://www.autoritedelaconcurrence.fr/sites/default/files/integral_texts/2020-06/19a18_0.pdf.
[42] Berardi, C., M. Hellowell and M. Varkevisser (2026), “A typology of private investor-ownership in health service provision and related regulatory frameworks in five countries”, Health Economics, Policy and Law, pp. 1-20, https://doi.org/10.1017/s1744133125100297.
[113] Borsa, A. et al. (2023), “Evaluating trends in private equity ownership and impacts on health outcomes, costs, and quality: systematic review”, BMJ, Vol. 382, p. e075244, https://doi.org/10.1136/bmj-2023-075244.
[108] Brekke, K. et al. (2021), “Hospital competition in a national health service: Evidence from a patient choice reform”, Journal of Health Economics, Vol. 79, p. 102509, https://doi.org/10.1016/j.jhealeco.2021.102509.
[9] Brook, R. et al. (2006), The Health Insurance Experiment: A Classic RAND Study Speaks to the Current Health Care Reform Debate, RAND Corporation, https://www.rand.org/pubs/research_briefs/RB9174.html.
[100] Bruch, J., S. Gondi and Z. Song (2020), “Changes in Hospital Income, Use, and Quality Associated With Private Equity Acquisition”, JAMA Internal Medicine, Vol. 180/11, p. 1428, https://doi.org/10.1001/jamainternmed.2020.3552.
[36] Brüll, E., D. Rostam-Afschar and O. Schlenker (2025), “Cut off from new competition: Threat of entry and quality of primary care”, Labour Economics, Vol. 92, p. 102669, https://doi.org/10.1016/j.labeco.2024.102669.
[97] Buri, R., M. Heinonen and M. Pietola (2024), The ones that got away? Stealth consolidation in the Finnish private healthcare market, Finnish Competition and Consumer Authority, https://www.kkv.fi/uploads/sites/2/01_2024_working-paper-the-ones-that-got-away.pdf.
[28] CADE (2019), Technical Co-operation Agreement, https://www.ans.gov.br/images/stories/noticias/pdf/Acordo_Cooperacao_CADE_ANS.pdf.
[54] Chen, Y. et al. (2023), “Impact of Diagnosis-Related Groups on Inpatient Quality of Health Care: A Systematic Review and Meta-Analysis”, INQUIRY: The Journal of Health Care Organization, Provision, and Financing, Vol. 60, https://doi.org/10.1177/00469580231167011.
[91] Cofece (2022), Study of competition in the health insurance market, https://www.cofece.mx/estudio-de-competencia-y-libre-concurrencia-en-seguros-de-gastos-medicos/.
[73] Collier, R. (2012), “Professionalism: The privilege and burden of self-regulation”, Canadian Medical Association Journal, Vol. 184/14, pp. 1559-1560, https://doi.org/10.1503/cmaj.109-4286.
[75] COMCO (2025), “La COMCO garantit l’accès au marché dans le domaine de la santé”, Communiqué de presse, https://www.admin.ch/fr/newnsb/HP-2eORlJHyi8-drfFc5v.
[67] Comisión Nacional de los Mercados y la Competencia (2016), The CNMC challenges the Government of Aragon’s Agreement on university education, which restricts competition in the university sector, https://www.cnmc.es/file/107313/download.
[78] Comisión Nacional de los Mercados y la Competencia (CNMC) (2026), Report on the proposal for the Ethical and Deontological Code of Spanish Nurses, https://www.cnmc.es/sites/default/files/6454502.pdf.
[24] Competition and Markets Authority (2023), Competition assessment: guidelines for policy makers, https://www.gov.uk/government/publications/competition-impact-assessment-guidelines-for-policymakers.
[32] Competition and Markets Authority (2016), Memorandum of understanding between the Competition and Markets Authority and NHS Improvement, https://assets.publishing.service.gov.uk/media/5a815b4840f0b62305b8e828/NHS_Improvement_MoU.pdf.
[29] Competition Bureau Canada (2023), Memorandum of Understanding between the Competition Bureau and Health Canada, https://www.canada.ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/memorandum-of-understanding-between-competition-bureau-health-canada.html.
[60] Competition Bureau Canada (2022), “Empowering health care providers in the digital era”, Digital Health Care Market Study – Part 3, https://competition-bureau.canada.ca/en/how-we-foster-competition/education-and-outreach/publications/Empowering-health-care-providers-in-the-digital-era.
[86] Competition Bureau Canada (2022), Unlocking the power of health data, https://competition-bureau.canada.ca/en/unlocking-power-health-data.
[30] Competition Bureau Canada (2020), Competition Bureau cracking down on deceptive marketing claims about COVID-19 prevention or treatment, https://www.canada.ca/en/competition-bureau/news/2020/05/competition-bureau-cracking-down-on-deceptive-marketing-claims-about-covid-19-prevention-or-treatment.html.
[21] Competition Bureau Canada (2020), Strengthening Canada’s economy through pro-competitive policies: A step-by-step guide to competition assessment, https://competition-bureau.canada.ca/en/strengthening-canadas-economy-through-pro-competitive-policies.
[50] de Lagasnerie, G. et al. (2015), “Tapering payments in hospitals: Experiences in OECD countries”, OECD Health Working Papers, No. 78, OECD Publishing, Paris, https://doi.org/10.1787/5js4h5rlkxxr-en.
[45] Department of Justice (2023), DOJ Letter on the Proposed Repeal of Alaska’s Certificate of Need Laws, https://www.justice.gov/atr/media/1302691/dl?inline.
[44] Department of Justice (2023), Healthcare Competition Advocacy, https://www.justice.gov/atr/health-care-competition-advocacy.
[77] Deyo, D., S. Ghosh and A. Plemmons (2024), Access to Care and Physician-Practice Growth after the Interstate Medical Licensure Compact, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4755497.
[72] Dillender, M. et al. (2023), “Occupational licensing and the healthcare labor market”, NBER Working Paper Series No. 29665, https://www.nber.org/system/files/working_papers/w29665/w29665.pdf.
[27] European Commission (2026), Pharmaceuticals & Health services, https://competition-policy.ec.europa.eu/sectors/pharmaceuticals-health-services_en (accessed on 2026 March 30).
[26] Federal Trade Commission (2026), “FTC Chairman Andrew N. Ferguson Launches Healthcare Task Force”, Press release, https://www.ftc.gov/news-events/news/press-releases/2026/03/ftc-chairman-andrew-n-ferguson-launches-healthcare-task-force.
[74] Federal Trade Commission (2026), “Letter from Office of Policy Planning Acting Director Clarke Edwards to Senator Juan Barnett Concerning Mississippi H.B. 1057 to Address the Practice of Advanced Practice Registered Nurses”, Matter Number P261201, https://www.ftc.gov/legal-library/browse/advocacy-filings/letter-office-policy-planning-acting-director-clarke-edwards-senator-juan-barnett-concerning.
[19] Federal Trade Commission (2022), FTC Staff Comment to the Food and Drug Administration in Docket No. FDA-2021-N-0555 Concerning Over-the-Counter Hearing Aids, https://www.ftc.gov/legal-library/browse/advocacy-filings/ftc-staff-comment-food-drug-administration-docket-no-fda-2021-n-0555-concerning-over-counter-hearing.
[94] Franken, F. et al. (2025), “Price transparency in the Dutch market-based health care system: did price dispersion for similar hospital services reduce over time?”, The European Journal of Health Economics, Vol. 26/7, pp. 1137-1147, https://doi.org/10.1007/s10198-025-01759-6.
[104] Gaynor, M. (2006), What Do We Know About Competition and Quality in Health Care Markets?, National Bureau of Economic Research, Cambridge, MA, https://doi.org/10.3386/w12301.
[14] Gaynor, M., K. Ho and R. Town (2015), “The Industrial Organization of Health-Care Markets”, Journal of Economic Literature, Vol. 53/2, pp. 235-284, https://doi.org/10.1257/jel.53.2.235.
[105] Gaynor, M., R. Moreno-Serra and C. Propper (2013), “Death by Market Power: Reform, Competition, and Patient Outcomes in the National Health Service”, American Economic Journal: Economic Policy, Vol. 5/4, pp. 134-166, https://doi.org/10.1257/pol.5.4.134.
[106] Gaynor, M., C. Propper and S. Seiler (2016), “Free to Choose? Reform, Choice, and Consideration Sets in the English National Health Service”, American Economic Review, Vol. 106/11, pp. 3521-3557, https://doi.org/10.1257/aer.20121532.
[17] Gaynor, M. and R. Town (2012), Competition in Health Care Markets, Elsevier B.V., https://doi.org/10.1016/B978-0-444-53592-4.00009-8.
[16] Gondi, S. and Z. Song (2019), “Potential Implications of Private Equity Investments in Health Care Delivery”, JAMA, Vol. 321/11, p. 1047, https://doi.org/10.1001/jama.2019.1077.
[52] Gosden, T. et al. (2000), “Capitation, salary, fee-for-service and mixed systems of payment: effects on the behaviour of primary care physicians”, Cochrane Database of Systematic Reviews, Vol. 2011/10, https://doi.org/10.1002/14651858.cd002215.
[90] Hellenic Competition Commission (2025), “Final Report of the Sector Inquiry on private health services and related insurance services”, Press release, https://www.epant.gr/en/information/press-releases/item/3220-press-release-final-report-of-the-sector-inquiry-on-private-health-services-and-related-insurance-services.html (accessed on 4 May 2026).
[33] Hellenic Competition Commission (2025), Sector inquiry into private health services and health insurance, https://www.epant.gr/en/information/sector-inquiries/health.html.
[71] Högberg, U. (2004), “The Decline in Maternal Mortality in Sweden”, American Journal of Public Health, Vol. 94/8, pp. 1312-1320, https://doi.org/10.2105/ajph.94.8.1312.
[95] Husiatynski, M. et al. (2021), Increasing price transparency in the Dutch healthcare market does not affect provider choice, https://cepr.org/publications/dp15981.
[102] Kannan, S. et al. (2025), “Hospital Staffing and Patient Outcomes After Private Equity Acquisition”, Annals of Internal Medicine, Vol. 178/11, pp. 1529-1538, https://doi.org/10.7326/annals-24-03471.
[81] Keelara, R., E. Sutherland and M. Almyranti (2025), “Leading practices for the future of telemedicine: Implementing telemedicine post-pandemic”, OECD Health Working Papers, No. 173, OECD Publishing, Paris, https://doi.org/10.1787/496a8ffe-en.
[22] KFTC (2023), Guidelines for reviewing competition restrictions such as laws and regulations, https://law.go.kr/LSW/admRulInfoP.do?admRulSeq=2100000233826.
[65] Konkurences padome (2026), KP concludes market surveillance on the conditions of competition in the field of health care services in Latvia, https://www.kp.gov.lv/lv/jaunums/kp-nosledz-tirgus-uzraudzibu-par-konkurences-apstakliem-veselibas-aprupes-pakalpojumu-joma-latvija.
[59] Konkurrensverket (2022), “The impact of private digital healthcare services on competitive conditions in primary care”, Report 2022:3, https://www.konkurrensverket.se/globalassets/dokument/informationsmaterial/rapporter-och-broschyrer/rapportserie/rapport_2022-3.pdf.
[93] Kwon, M. and L. Zhang (2025), “Price Transparency in Healthcare: Understanding the Impacts of the Price Disclosure Policy in Maine”, Production and Operations Management, https://doi.org/10.1177/10591478251408901.
[99] La Forgia, A. et al. (2022), “Association of Physician Management Companies and Private Equity Investment With Commercial Health Care Prices Paid to Anesthesia Practitioners”, JAMA Internal Medicine, Vol. 182/4, p. 396, https://doi.org/10.1001/jamainternmed.2022.0004.
[68] Law, M. and S. Kim (2005), “Specialization and Regulation: The Rise of Professionals and the Emergence of Occupational Licensing Regulation”, The Journal of Economic History, Vol. 65/03, https://doi.org/10.1017/s0022050705000264.
[70] Lazuka, V. (2018), “The long-term health benefits of receiving treatment from qualified midwives at birth”, Journal of Development Economics, Vol. 133, pp. 415-433, https://doi.org/10.1016/j.jdeveco.2018.03.007.
[48] Lindner, L. and L. Lorenzoni (2023), “Innovative providers’ payment models for promoting value-based health systems: Start small, prove value, and scale up”, OECD Health Working Papers, No. 154, OECD Publishing, Paris, https://doi.org/10.1787/627fe490-en.
[103] Lin, H. et al. (2023), “Private equity and healthcare firm behavior: Evidence from ambulatory surgery centers”, Journal of Health Economics, Vol. 91, p. 102801, https://doi.org/10.1016/j.jhealeco.2023.102801.
[96] Mariani, M. et al. (2022), “Impact of hospital mergers: a systematic review focusing on healthcare quality measures”, European Journal of Public Health, Vol. 32/2, pp. 191-199, https://doi.org/10.1093/eurpub/ckac002.
[51] McGuire, T. (2000), “Physician Agency”, in Handbook of Health Economics, Elsevier, https://doi.org/10.1016/s1574-0064(00)80168-7.
[89] Méndez, S. et al. (2026), “Price Transparency in Specialist Markets”, Australian Economic Review, Vol. 59/1, pp. 119-122, https://doi.org/10.1111/1467-8462.70051.
[82] Mendez, S., J. Young and Y. Zhang (2025), Submission to the Productivity Commission: in reponse to the interim report on Delivering quality care more efficiently, https://engage.pc.gov.au/projects/quality-care/page/pillar-4-responses.
[55] Milcent, C. (2020), “From downcoding to upcoding: DRG based payment in hospitals”, International Journal of Health Economics and Management, Vol. 21/1, pp. 1-26, https://doi.org/10.1007/s10754-020-09287-x.
[57] Milstein, R. and J. Schreyögg (2024), “The end of an era? Activity-based funding based on diagnosis-related groups: A review of payment reforms in the inpatient sector in 10 high-income countries”, Health Policy, Vol. 141, p. 104990, https://doi.org/10.1016/j.healthpol.2023.104990.
[37] Mitchell, M. (2024), “Certificate of Need Laws in Health Care: Past, Present, and Future”, INQUIRY: The Journal of Health Care Organization, Provision, and Financing, Vol. 61, https://doi.org/10.1177/00469580241251937.
[62] Monopolkommission (2023), Policy Brief: Adjusting maintenance allowances for hospitals, securing supply needs, maintaining competition (Issue 11), https://www.monopolkommission.de/images/Policy_Brief/MK_Policy_Brief_11.pdf.
[61] Monopolkommission (2022), Hospital Care After COVID-19: Reorganizing Competition, Planning, and Financing (Special Report 83), https://www.monopolkommission.de/images/PDF/SG/SG83_volltext.pdf.
[107] Moscelli, G., H. Gravelle and L. Siciliani (2023), “The effect of hospital choice and competition on inequalities in waiting times”, Journal of Economic Behavior & Organization, Vol. 205, pp. 169-201, https://doi.org/10.1016/j.jebo.2022.10.040.
[23] New Zealand Commerce Commission (2023), Competition assessment guidelines – January 2023, https://www.comcom.govt.nz/about-us/our-policies-and-guidelines/competition-assessment-guidelines/.
[85] OECD (2025), “Artificial intelligence and competitive dynamics in downstream markets”, OECD Roundtables on Competition Policy Papers, No. 331, OECD Publishing, Paris, https://doi.org/10.1787/ccf0624a-en.
[5] OECD (2025), Competition in healthcare markets: Access, quality and equity, https://one.oecd.org/document/DAF/COMP/GF(2025)5/en/pdf.
[64] OECD (2025), Competition in the Healthcare Sector – Contribution from Latvia, Global Forum on Competition, DAF/COMP/GF/WD(2025)52, https://one.oecd.org/document/DAF/COMP/GF/WD(2025)52/en/pdf.
[66] OECD (2025), Competition in the Healthcare Sector – Contribution from Lithuania, Global Forum on Competition, DAF/COMP/GF/WD(2025)50, https://one.oecd.org/document/DAF/COMP/GF/WD(2025)50/en/pdf.
[6] OECD (2025), Competition risks across the pharmaceutical value chain, https://one.oecd.org/document/DAF/COMP/GF(2025)6/en/pdf.
[83] OECD (2025), Does Healthcare Deliver?: Results from the Patient-Reported Indicator Surveys (PaRIS), OECD Publishing, Paris, https://doi.org/10.1787/c8af05a5-en.
[1] OECD (2025), Health at a Glance 2025: OECD Indicators, OECD Publishing, Paris, https://doi.org/10.1787/8f9e3f98-en.
[84] OECD (2025), “Personal health data systems in OECD countries: Insights into structures and solutions for public access and use”, OECD Health Working Papers, No. 187, OECD Publishing, Paris, https://doi.org/10.1787/0d118bb0-en.
[34] OECD (2024), “Competition and regulation in professions and occupations”, OECD Roundtables on Competition Policy Papers, No. 307, OECD Publishing, Paris, https://doi.org/10.1787/218869f5-en.
[111] OECD (2024), “Competition and regulation in the care industry”, OECD Roundtables on Competition Policy Papers, No. 315, OECD Publishing, Paris, https://doi.org/10.1787/cef35d7c-en.
[20] OECD (2024), Competitive Neutrality Toolkit: Promoting a Level Playing Field, OECD Publishing, Paris, https://doi.org/10.1787/3247ba44-en.
[110] OECD (2023), “Serial Acquisitions and Industry Roll-ups”, OECD Roundtables on Competition Policy Papers, No. 303, OECD Publishing, Paris, https://doi.org/10.1787/0b4362f8-en.
[117] OECD (2022), “Interactions between Competition Authorities and Sector Regulators ”, OECD Roundtables on Competition Policy Papers, No. 285, OECD Publishing, Paris, https://doi.org/10.1787/b85b4140-en.
[87] OECD (2021), “Data Portability, Interoperability and Competition”, OECD Roundtables on Competition Policy Papers, No. 260, OECD Publishing, Paris, https://doi.org/10.1787/73a083a9-en.
[7] OECD (2019), Competition Assessment Toolkit: Operational Manual. Version 4.0 (Volume 3), OECD Publishing, Paris, https://doi.org/10.1787/1f253011-en.
[2] OECD (2018), “Designing Publicly Funded Healthcare Markets”, OECD Roundtables on Competition Policy Papers, No. 223, OECD Publishing, Paris, https://doi.org/10.1787/abdb4787-en.
[47] OECD (2016), Better Ways to Pay for Health Care, OECD Health Policy Studies, OECD Publishing, Paris, https://doi.org/10.1787/9789264258211-en.
[3] OECD (2012), Competition in Hospital Services, https://www.oecd.org/content/dam/oecd/en/publications/reports/2012/06/competition-in-hospital-services_b3424710/d525b95a-en.pdf.
[4] OECD/The Health Foundation (2025), How Do Health System Features Influence Health System Performance?, OECD Publishing, Paris, https://doi.org/10.1787/7b877762-en.
[25] Office of Information and Regulatory Affairs and Office of Management and Budget (2023), Guidance on Accounting for Competition Effects when Developing and Analysing Regulatory Actions, https://bidenwhitehouse.archives.gov/wp-content/uploads/2023/10/RegulatoryCompetitionGuidance.pdf.
[38] Or, Z. et al. (2020), “Impact of Competition Versus Centralisation of Hospital Care on Process Quality: A Multilevel Analysis of Breast Cancer Surgery in France”, International Journal of Health Policy and Management, https://doi.org/10.34172/ijhpm.2020.179.
[92] Pan, X. and N. Yaraghi (2025), “From Hidden Fees to Open Books: An Empirical Examination of the Impact of Hospital Price Transparency Rule on Costs and Quality of Medical Services”, Production and Operations Management, Vol. 35/3, pp. 1113-1132, https://doi.org/10.1177/10591478251367520.
[12] Pitkänen, V. and I. Linnosmaa (2021), “Choice, quality and patients’ experience: evidence from a Finnish physiotherapy service”, International Journal of Health Economics and Management, Vol. 21/2, pp. 229-245, https://doi.org/10.1007/s10754-020-09293-z.
[10] Prager, E. (2020), “Healthcare Demand under Simple Prices: Evidence from Tiered Hospital Networks”, American Economic Journal: Applied Economics, Vol. 12/4, pp. 196-223, https://doi.org/10.1257/app.20180422.
[76] Productivity Commission (2023), “5-year Productivity Inquiry: A more productive labour market”, Inquiry Report - volume 7, https://assets.pc.gov.au/inquiries/completed/productivity/report/productivity-volume7-labour-market.pdf.
[13] Propper, C. (2026), “Do markets deliver? Competition and Choice in European healthcare markets”, The Economic Journal, https://doi.org/10.1093/ej/ueag033.
[101] Richards, M. and C. Whaley (2024), “Hospital behavior over the private equity life cycle”, Journal of Health Economics, Vol. 97, p. 102902, https://doi.org/10.1016/j.jhealeco.2024.102902.
[40] Rooke-Ley, H. et al. (2025), “The Corporate Backdoor toMedicine: How MSOs AreReshaping Physician Practices”, Issue Brief, Milbank Memorial Fund, https://www.milbank.org/wp-content/uploads/2025/04/MSO-Policy-Brief_4.16-1.pdf.
[115] Roos, A. et al. (2020), “Does price deregulation in a competitive hospital market damage quality?”, Journal of Health Economics, Vol. 72, p. 102328, https://doi.org/10.1016/j.jhealeco.2020.102328.
[63] Samkeppniseftirlitið (2026), Ministry of Health announces increased equity in healthcare following SKE recommendations – it is important that they are implemented, https://www.samkeppni.is/en/release/news/the-ministry-of-health-is-calling-for-increased-equity-in-healthcare-following-recommendations-it-is-crucial-that-these-are-implemented/.
[98] Scheffler, R. et al. (2023), Monetizing Medicine: Private Equity and Competition in Physician Practice Markets, American Antitrust Institute, Petris Center, Washington Center for Equitable Growth, https://www.antitrustinstitute.org/wp-content/uploads/2023/07/AAI-UCB-EG_Private-Equity-I-Physician-Practice-Report_FINAL.pdf.
[49] Scheller-Kreinsen, D., W. Quentin and R. Busse (2011), “DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries”, Value in Health, Vol. 14/8, pp. 1166-1172, https://doi.org/10.1016/j.jval.2011.07.001.
[53] Scott, A. et al. (2011), “The effect of financial incentives on the quality of health care provided by primary care physicians”, Cochrane Database of Systematic Reviews, https://doi.org/10.1002/14651858.cd008451.pub2.
[11] Siciliani, L., M. Chalkley and H. Gravelle (2022), “Does provider competition improve health care quality and efficiency? Expectations and evidence from Europe”, Policy Brief, https://eurohealthobservatory.who.int/publications/i/does-provider-competition-improve-health-care-quality-and-efficiency-expectations-and-evidence-from-europe.
[116] Sinaiko, A. (2026), “Anticompetitive Contracts Between Insurers and Providers in Health Care”, Journal of Economic Perspectives, Vol. 40/2, pp. 69-92, https://doi.org/10.1257/jep.20251471.
[109] Singh, Y. et al. (2026), “Private equity investments in health care in OECD countries: an exploratory analysis”, Health Economics, Policy and Law, pp. 1-28, https://doi.org/10.1017/s1744133125100352.
[43] Superintendencia de Industria y Comercio (2023), Estudio económico: Consideraciones sobre la definición del mercado relevante para la Enfermedad Renal Crónica en Colombia, https://www.sic.gov.co/sites/default/files/23092898--0011200002.pdf.
[15] Suzuki, E. et al. (2025), “Trends in the financialisation of outpatient care across OECD countries: What do we know?”, OECD Health Working Papers, No. 179, OECD Publishing, Paris, https://doi.org/10.1787/f5d88b41-en.
[80] US Federation of State Medical Boards (2024), Telemedicine Policies, Board-by-Board Overview, https://www.fsmb.org/siteassets/advocacy/key-issues/telemedicine_policies_by_state.pdf (accessed on 10 April 2026).
[39] van der Schors, W. et al. (2022), “Associations of hospital volume and hospital competition with short-term, middle-term and long-term patient outcomes after breast cancer surgery: a retrospective population-based study”, BMJ Open, Vol. 12/4, p. e057301, https://doi.org/10.1136/bmjopen-2021-057301.
[41] van der Schors, W., R. Kemp and M. Varkevisser (2020), “Collaboration and Competition Policy in a Market-Based Hospital System: A Case Study from the Netherlands”, Journal of Competition Law & Economics, Vol. 16/2, pp. 262-288, https://doi.org/10.1093/joclec/nhaa009.
[114] Varkevisser, M., C. Capps and F. Schut (2008), “Defining hospital markets for antitrust enforcement: new approaches and their applicability to The Netherlands”, Health Economics, Policy and Law, Vol. 3/1, pp. 7-29, https://doi.org/10.1017/s1744133107004331.
[18] Volpp, K. et al. (2005), “The Effects of Price Competition and Reduced Subsidies for Uncompensated Care on Hospital Mortality”, Health Services Research, Vol. 40/4, pp. 1056-1077, https://doi.org/10.1111/j.1475-6773.2005.00396.x.
[58] Wagenschieber, E. and D. Blunck (2024), “Impact of reimbursement systems on patient care – a systematic review of systematic reviews”, Health Economics Review, Vol. 14/1, https://doi.org/10.1186/s13561-024-00487-6.
[56] Waitzberg, R. et al. (2024), “Balancing financial incentives during COVID-19: A comparison of provider payment adjustments across 20 countries”, Health Policy, Vol. 126/5, pp. 398-407, https://doi.org/10.1016/j.healthpol.2021.09.015.
[35] World Health Organization (2025), “Purchasing healthcare from the private sector: a primer for middle-income countries in the WHO European Region”, Health Financing Policy Papers, https://iris.who.int/server/api/core/bitstreams/b1d77d8a-50b9-443f-afcb-82bef2616370/content.
[8] Zweifel, P. and W. Manning (2000), “Chapter 8 Moral hazard and consumer incentives in health care”, in Handbook of Health Economics, Elsevier, https://doi.org/10.1016/s1574-0064(00)80167-5.